>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:

XCO +17.2%, GALE +15.3%, PRTO +11.8%, FRSH +11.7%, IDRA +11.5%,ALRM +10.3%, GPRO +10.2%, SKLN +8.2%, ITEK +7.2%
JASO +6.6%, CLRB +6.2%, ORCL +6.2%, SAEX +5.8%, MCRB +5.2%, SNOA +4.8%, RMTI +3.6%, CPRX +3.2%, SYNC +3.2%
WSM +3.1%, RTK +2.7%, CALL +1.9%, YRD +1.4%, EVOK +1.3%, BTG +1%

M&A news:

KGC +1.2% (Confirms that it has received an unsolicited proposal from Virtu Financial (VIRT) for $18.50-$20.00 per share in cash)

Select EU financial related names showing strength:

Select metals/mining stocks trading higher:

SWC +2.7%, AG +2.6%, BBL +1.8%, FCX +1.6%, BHP +1.5%, VALE +1.5%
SSRI +1.4%, PAAS +1.4%, CLF +1.3%, GOLD +1%, AEM +1%

Other news:

HTBX +13% (receivse a 3 year, $982k grant from the Florida Department of Health 2016-17 Zika Research Grant Initiative to further develop and test gp96-based Zika vaccine)
MCRB +5.2% (Seres Therapeutics and FDA reach agreement on key design elements of a new SER-109 Phase 2 study)
CTSO +3.9% (enters into a partnership with Dr. Reddy's Laboratories (RDY) for the South African market)
TLND +3.2% (upsizes and prices offering by selling shareholders of 3,289,662 ADSs at $28.50 per share)
TSLA +3% (Announces offerings of $250 mln of common stock and $750 mln aggregate principal amount of convertible senior notes due in 2022 in concurrent underwritten registered public offerings)
DO +2.3% (Updates on injunction vs. Petrobras (PBR) regarding the Ocean Valor)
EXK +2.3% (announces that exploration drilling on the Terronera property)
AMRN +2.2% (reports REDUCE-IT Cardiovascular outcomes study remains on schedule to reach onset of target final primary major adverse cardiovascular event near the end of 2017)
BKS +1.7% (Board authorizes new stock repurchase program of up to $50 mln of its common shares)
SPWR +1.7% (Enters into a Project Supply Agreement with Next Era Energy Resources
SAP +1.4% (in sympathy with ORCL earnings)
EQC +1.3% (Board adds $150 mln to buyback program)

Analyst comments: